Research Radar · Aug 20, 2026
Petrelintide: The Amylin Analog Betting On Tolerability Instead Of Peak Numbers
0Sign in to vote or save
Roche paid $5.3 billion for a drug that loses on weight loss. Here’s the argument behind that.
Research Radar · Aug 20, 2026
Roche paid $5.3 billion for a drug that loses on weight loss. Here’s the argument behind that.
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.